메뉴 건너뛰기




Volumn 17, Issue 8, 2010, Pages 767-775

Ethinylestradio-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: Evaluation of the metabolic impact

Author keywords

androgens; chlormadinone; hirsutism; metabolism; PCOS

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROXYPROGESTERONE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; CHLORMADINONE ACETATE; DRUG DERIVATIVE; ETHINYLESTRADIOL; ETHINYLESTRADIOL CHLORMADINONE ACETATE; ETHINYLESTRADIOL-CHLORMADINONE ACETATE; ORAL CONTRACEPTIVE AGENT;

EID: 77954322923     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110371515     Document Type: Article
Times cited : (7)

References (52)
  • 1
    • 0029095150 scopus 로고
    • Polycystic ovary syndrome
    • Franks S. Polycystic ovary syndrome. New Engl J Med. 1995 ; 333 (13). 853-861.
    • (1995) New Engl J Med. , vol.333 , Issue.13 , pp. 853-861
    • Franks, S.1
  • 2
    • 0025634135 scopus 로고
    • Long term treatment with the combination ethinyl-estradiol and cyproterone acetate in polycystic ovary syndrome
    • Falsetti L., Galbignani E. Long term treatment with the combination ethinyl-estradiol and cyproterone acetate in polycystic ovary syndrome. Contraception. 1990 ; 42 (6). 611-619.
    • (1990) Contraception , vol.42 , Issue.6 , pp. 611-619
    • Falsetti, L.1    Galbignani, E.2
  • 3
    • 42149163918 scopus 로고    scopus 로고
    • Conway. A systemic review of commonly used medical treatments for hirsutism in women
    • Olympia K., Gerard S. Conway. A systemic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol. 2008 ; 68 (5). 800-805.
    • (2008) Clin Endocrinol , vol.68 , Issue.5 , pp. 800-805
    • Olympia, K.1    Gerard, S.2
  • 4
  • 8
    • 19244367470 scopus 로고    scopus 로고
    • Acute myocardial infarction and combined oral contraceptives: Results of international multicenter case-control study
    • WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception
    • WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of international multicenter case-control study. Lancet. 1997 ; 349 (9060). 1202-1209.
    • (1997) Lancet , vol.349 , Issue.9060 , pp. 1202-1209
  • 9
    • 0035984973 scopus 로고    scopus 로고
    • Long-term health consequences of PCOS
    • Wild RA Long-term health consequences of PCOS. Hum Reprod Update. 2002 ; 8 (3). 231-241.
    • (2002) Hum Reprod Update , vol.8 , Issue.3 , pp. 231-241
    • Wild, R.A.1
  • 10
    • 0034838348 scopus 로고    scopus 로고
    • Acne resolution rates: Results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon)
    • Worret I., Arp W., Zahradnik HP, Zahradnik HP, Andreas JO, Binder N. Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). Dermatology. 2001 ; 203 (1). 38-44.
    • (2001) Dermatology , vol.203 , Issue.1 , pp. 38-44
    • Worret, I.1    Arp, W.2    Zahradnik, H.P.3    Zahradnik, H.P.4    Andreas, J.O.5    Binder, N.6
  • 11
    • 0037383049 scopus 로고    scopus 로고
    • A 12-month evaluation of the CMAcontaining oral contraceptive Belara: Efficacy, tolerability and anti-androgenic properties
    • Schramm G., Steffens D. A 12-month evaluation of the CMAcontaining oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties. Contraception. 2003 ; 67 (4). 305-312.
    • (2003) Contraception , vol.67 , Issue.4 , pp. 305-312
    • Schramm, G.1    Steffens, D.2
  • 12
    • 71149100877 scopus 로고    scopus 로고
    • Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: Physical and emotional benefits
    • Heskamp ML, Schramm GA Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: physical and emotional benefits. Contraception. 2010 ; 81 (1). 49-56.
    • (2010) Contraception. , vol.81 , Issue.1 , pp. 49-56
    • Heskamp, M.L.1    Schramm, G.A.2
  • 13
    • 61449101283 scopus 로고    scopus 로고
    • Profile of the progesterone derivative chlormadinone acetate- pharmocodynamic properties and therapeutic applications
    • Druckmann R. Profile of the progesterone derivative chlormadinone acetate-pharmocodynamic properties and therapeutic applications. Contraception. 2009 ; 79 (4). 272-281.
    • (2009) Contraception , vol.79 , Issue.4 , pp. 272-281
    • Druckmann, R.1
  • 14
    • 29044448524 scopus 로고    scopus 로고
    • Chlormadinone acetate (CMA) in oral contraception-a new opportunity
    • Bouchard P. Chlormadinone acetate (CMA) in oral contraception-a new opportunity. Eur J Contracept Reprod Health Care. 2005 ; 10 (suppl 1). 7-11.
    • (2005) Eur J Contracept Reprod Health Care , vol.10 , Issue.1 , pp. 7-11
    • Bouchard, P.1
  • 15
    • 67349136077 scopus 로고    scopus 로고
    • Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: A randomized, double-blind, placebo-controlled Phase III trial
    • Plewig G., Cunliffe WJ, Binder N., Höschen K. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial. Contraception. 2009 ; 80 (1). 25-33.
    • (2009) Contraception. , vol.80 , Issue.1 , pp. 25-33
    • Plewig, G.1    Cunliffe, W.J.2    Binder, N.3    Höschen, K.4
  • 16
    • 0036075587 scopus 로고    scopus 로고
    • Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment
    • Carranza-Lira S., Magaà±a-Padilla NR Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment. Ginecol Obstet Mex. 2002 ; 70 (6). 285-288.
    • (2002) Ginecol Obstet Mex. , vol.70 , Issue.6 , pp. 285-288
    • Carranza-Lira, S.1    Magaàa-Padilla, N.R.2
  • 17
    • 0343832020 scopus 로고    scopus 로고
    • The relation of the gonadotrophin response to chlormadinone according to body weight in patients with amenorrhea due to polycystic ovarian syndrome
    • Carranza-Lira S., Garcàa-Hernández E., Baiza MR, Morán C. The relation of the gonadotrophin response to chlormadinone according to body weight in patients with amenorrhea due to polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 1996 ; 66 (2). 161-164.
    • (1996) Eur J Obstet Gynecol Reprod Biol , vol.66 , Issue.2 , pp. 161-164
    • Carranza-Lira, S.1    Garcàa-Hernández, E.2    Baiza, M.R.3    Morán, C.4
  • 19
    • 0346186090 scopus 로고    scopus 로고
    • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
    • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 ; 19 (1). 41-47.
    • (2004) Hum Reprod , vol.19 , Issue.1 , pp. 41-47
  • 20
    • 0034901923 scopus 로고    scopus 로고
    • A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: The ovarian stroma/total area ratio
    • Fulghesu AM, Ciampelli M., Belosi C., et al. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril. 2001 ; 76 (2). 326-331.
    • (2001) Fertil Steril , vol.76 , Issue.2 , pp. 326-331
    • Fulghesu, A.M.1    Ciampelli, M.2    Belosi, C.3
  • 21
    • 0032833231 scopus 로고    scopus 로고
    • Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 years old adolescents
    • Van Hooff MH, Voorhorst FJ, et al. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 years old adolescents. Hum Reprod. 1999 ; 14 (9). 2223-2229.
    • (1999) Hum Reprod , vol.14 , Issue.9 , pp. 2223-2229
    • Van Hooff, M.H.1    Voorhorst, F.J.2
  • 22
    • 0020556434 scopus 로고
    • Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data
    • New MI, Lorenzen F., Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab. 1983 ; 57 (2). 320-326.
    • (1983) J Clin Endocrinol Metab , vol.57 , Issue.2 , pp. 320-326
    • New, M.I.1    Lorenzen, F.2    Lerner, A.J.3
  • 23
    • 12644305063 scopus 로고
    • Clinical assessment of body hair growth in women
    • Ferriman D., Gallwey JD Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961 ; 21: 1440-1447.
    • (1961) J Clin Endocrinol Metab , vol.21 , pp. 1440-1447
    • Ferriman, D.1    Gallwey, J.D.2
  • 25
    • 0018520840 scopus 로고
    • Glucose clamp technique: A method for quantifying insulin secretion and resistance
    • De Fronzo JP, Tobin JD, Andrei R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 ; 237 (3). E214 - E223.
    • (1979) Am J Physiol. , vol.237 , Issue.3
    • De Fronzo, J.P.1    Tobin, J.D.2    Andrei, R.3
  • 26
    • 0022361971 scopus 로고
    • Assessment of insulin sensitivity in vivo
    • Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985 ; 6 (1). 45-86.
    • (1985) Endocr Rev , vol.6 , Issue.1 , pp. 45-86
    • Bergman, R.N.1    Finegood, D.T.2    Ader, M.3
  • 27
    • 0033007007 scopus 로고    scopus 로고
    • Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome
    • Ciampelli M., Fulghesu AM, Cucinelli F., et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism. 1999 ; 48 (2). 167-172.
    • (1999) Metabolism , vol.48 , Issue.2 , pp. 167-172
    • Ciampelli, M.1    Fulghesu, A.M.2    Cucinelli, F.3
  • 28
    • 0032739105 scopus 로고    scopus 로고
    • The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices
    • Rivera R., Yacobson I., Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999 ; 181 (5 Pt 1). 1263-1269.
    • (1999) Am J Obstet Gynecol. , vol.181 , Issue.5 PART 1 , pp. 1263-1269
    • Rivera, R.1    Yacobson, I.2    Grimes, D.3
  • 29
    • 0032034169 scopus 로고    scopus 로고
    • Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism
    • Crook D., Godsland I. Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Contraception. 1998 ; 57 (3). 189-201.
    • (1998) Contraception , vol.57 , Issue.3 , pp. 189-201
    • Crook, D.1    Godsland, I.2
  • 30
    • 0019215829 scopus 로고
    • Insulin receptors on monocytes and erythrocytes from obese patients
    • De Pirro R., Fusco A., Lauro R., et al. Insulin receptors on monocytes and erythrocytes from obese patients. J Clin Endocrinol Metab. 1980 ; 51 (6). 1437-1439.
    • (1980) J Clin Endocrinol Metab , vol.51 , Issue.6 , pp. 1437-1439
    • De Pirro, R.1    Fusco, A.2    Lauro, R.3
  • 31
    • 0026579457 scopus 로고
    • Insulin resistance, secretion, and metabolism in users of oral contraceptives
    • Godsland IF, Walton C., Felton C., et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 1992 ; 74 (1). 64-70.
    • (1992) J Clin Endocrinol Metab , vol.74 , Issue.1 , pp. 64-70
    • Godsland, I.F.1    Walton, C.2    Felton, C.3
  • 32
    • 13544263383 scopus 로고    scopus 로고
    • A 1-yr randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 1/4g ethinyl estradiol combined with 100 1/4g levonorgesterel
    • Skouby SO, Endrikat J., Dusterberg B., et al. A 1-yr randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 1/4g ethinyl estradiol combined with 100 1/4g levonorgesterel. Contraception. 2005 ; 71 (2). 111-117.
    • (2005) Contraception , vol.71 , Issue.2 , pp. 111-117
    • Skouby, S.O.1    Endrikat, J.2    Dusterberg, B.3
  • 33
    • 42449157428 scopus 로고    scopus 로고
    • Steroidal contraceptives: Effect on carbohydrate metabolism in women without diabetes mellitus
    • Lopez LM, Grimes DA, Schulz KF Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst Rev. 2007 ;(2). CD006133.
    • (2007) Cochrane Database Syst Rev. , Issue.2 , pp. 006133
    • Lopez, L.M.1    Grimes, D.A.2    Schulz, K.F.3
  • 34
    • 0242286063 scopus 로고    scopus 로고
    • Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism
    • Làdicke F., Gaspard UJ, Demeyer F., Scheen A., Lefebvre P. Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism. Contraception. 2002 ; 66 (6). 411-415.
    • (2002) Contraception , vol.66 , Issue.6 , pp. 411-415
    • Làdicke, F.1    Gaspard, U.J.2    Demeyer, F.3    Scheen, A.4    Lefebvre, P.5
  • 35
    • 84995865301 scopus 로고
    • Induction of insulin resistance by estrogens and androgens
    • Polderman KH, Gooren LJG, Asscheman H., et al. Induction of insulin resistance by estrogens and androgens. J Clin Endocrinol Metab. 1994 ; 79 (1). 265-271.
    • (1994) J Clin Endocrinol Metab , vol.79 , Issue.1 , pp. 265-271
    • Polderman, K.H.1    Ljg, G.2    Asscheman, H.3
  • 36
    • 77952787136 scopus 로고    scopus 로고
    • Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
    • Wild RA, Carmina E., Diamanti-Kandarakis E., Dokras A., et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010 May; 95 (5). 2038-2049.
    • (2010) J Clin Endocrinol Metab. , vol.95 , Issue.5 , pp. 2038-2049
    • Wild, R.A.1    Carmina, E.2    Diamanti-Kandarakis, E.3    Dokras, A.4
  • 37
    • 58149147337 scopus 로고    scopus 로고
    • Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: A randomized trial
    • Cagnacci A., Ferrari S., Tirelli A., et al. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial. Contraception. 2009 ; 79 (2). 111-116.
    • (2009) Contraception. , vol.79 , Issue.2 , pp. 111-116
    • Cagnacci, A.1    Ferrari, S.2    Tirelli, A.3
  • 38
    • 56549093574 scopus 로고    scopus 로고
    • The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters
    • Winkler UH, Sudik R. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters. Contraception. 2009 ; 79 (2). 15-23.
    • (2009) Contraception. , vol.79 , Issue.2 , pp. 15-23
    • Winkler, U.H.1    Sudik, R.2
  • 39
    • 17044444359 scopus 로고
    • Comparative evaluation of the androgenecity of four low-dose, fixed combination oral contraceptives
    • Coenen C., Thomas C., Borm G., et al. Comparative evaluation of the androgenecity of four low-dose, fixed combination oral contraceptives. Int J Fertil. 1995 ; 40 (suppl 2). 92-97.
    • (1995) Int J Fertil , vol.40 , Issue.2 , pp. 92-97
    • Coenen, C.1    Thomas, C.2    Borm, G.3
  • 40
    • 18444372363 scopus 로고    scopus 로고
    • Uddin M. Effects of low dose oral contraceptives on serum total cholesterol, TAG, HDL-C & LDL-C levels in contraceptive users
    • Nessa A., Latif SA, Uddin M. Effects of low dose oral contraceptives on serum total cholesterol, TAG, HDL-C & LDL-C levels in contraceptive users. Mymensingh Med J. 2005 ; 14 (1). 26-28.
    • (2005) Mymensingh Med J , vol.14 , Issue.1 , pp. 26-28
    • Nessa, A.1    Latif, S.A.2
  • 41
    • 0038531042 scopus 로고    scopus 로고
    • Serum lipid and lipoprotein changes induced by preparations containing low-dose ethinylestradiol plus levonorgestrel
    • Kiran G., Kiran H., Ekerbicer HC, Aust NZ Serum lipid and lipoprotein changes induced by preparations containing low-dose ethinylestradiol plus levonorgestrel. J Obstet Gynaecol. 2003 ; 43 (2). 145-147.
    • (2003) J Obstet Gynaecol , vol.43 , Issue.2 , pp. 145-147
    • Kiran, G.1    Kiran, H.2    Ekerbicer, H.C.3    Aust, N.Z.4
  • 42
    • 0032415718 scopus 로고    scopus 로고
    • The new pathophysiology of coronary artery disease
    • Castelli WP The new pathophysiology of coronary artery disease. Am J Cardiol. 1998 ; 82 (10B). 60t - 65t.
    • (1998) Am J Cardiol. , vol.82 , Issue.10 B
    • Castelli, W.P.1
  • 43
    • 0035059042 scopus 로고    scopus 로고
    • Cardiovascular risk factors and prevention in women: Similarities and differences
    • Sclavo M. Cardiovascular risk factors and prevention in women: similarities and differences. Ital Heart J. 2001 ; 2 (suppl 2). 125-141.
    • (2001) Ital Heart J , vol.2 , Issue.2 , pp. 125-141
    • Sclavo, M.1
  • 44
    • 0029766983 scopus 로고    scopus 로고
    • Regulation of VLDL synthesis and secretion in the liver
    • Gruffat D., Durand D., Graulet B., Bauchart D. Regulation of VLDL synthesis and secretion in the liver. Reprod Nutr Dev. 1996 ; 36 (4). 375-389. Review.
    • (1996) Reprod Nutr Dev. , vol.36 , Issue.4 , pp. 375-389
    • Gruffat, D.1    Durand, D.2    Graulet, B.3    Bauchart, D.4
  • 45
    • 0020641610 scopus 로고
    • Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol
    • Wahl R., Walden C., Knopp R., et al. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med. 1993 ; 308 (15). 862-867.
    • (1993) N Engl J Med. , vol.308 , Issue.15 , pp. 862-867
    • Wahl, R.1    Walden, C.2    Knopp, R.3
  • 46
    • 0027287971 scopus 로고
    • Effects of low dose oral contraceptive on very low density lipoprotein metabolism
    • Walsh BW, Sacks FM Effects of low dose oral contraceptive on very low density lipoprotein metabolism. J. Clin Invest. 1993 ; 91 (5). 2126-2132.
    • (1993) J. Clin Invest , vol.91 , Issue.5 , pp. 2126-2132
    • Walsh, B.W.1    Sacks, F.M.2
  • 47
    • 35348965152 scopus 로고    scopus 로고
    • Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents
    • Sabatini R., Orsini G., Cagiano R., et al. Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents. Contraception. 2007 ; 76 (5). 342-347.
    • (2007) Contraception , vol.76 , Issue.5 , pp. 342-347
    • Sabatini, R.1    Orsini, G.2    Cagiano, R.3
  • 48
    • 0037228146 scopus 로고    scopus 로고
    • Progestogens with antiandrogenic properties
    • Raudrant D., Rabe T. Progestogens with antiandrogenic properties. Drug. 2003 ; 63 (5). 463-492.
    • (2003) Drug , vol.63 , Issue.5 , pp. 463-492
    • Raudrant, D.1    Rabe, T.2
  • 49
    • 0037203511 scopus 로고    scopus 로고
    • Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line
    • Tà©rouanne B., Paris F., Servant N., Georget V., Sultan C. Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line. Mol Cell Endocrinol. 2002 ; 198 (1-2). 143-147.
    • (2002) Mol Cell Endocrinol , vol.198 , Issue.1-2 , pp. 143-147
    • Tàrouanne, B.1    Paris, F.2    Servant, N.3    Georget, V.4    Sultan, C.5
  • 50
    • 0030693350 scopus 로고    scopus 로고
    • Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
    • Lucky AW, Henderson TA, Olson WH, et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997 ; 37 (5 pt 1). 746-754.
    • (1997) J Am Acad Dermatol. , vol.37 , Issue.5 PART 1 , pp. 746-754
    • Lucky, A.W.1    Henderson, T.A.2    Olson, W.H.3
  • 51
    • 0029103321 scopus 로고
    • Chlormadinone acetate as a possible effecrive agent for congenital adrenal hyperplasia to suppress elevated ACTH and antagonize masculinization
    • Kageyama Y., Kitahara S., Tsukamoto T., Tsujii T., Goto S., Oshima H. Chlormadinone acetate as a possible effecrive agent for congenital adrenal hyperplasia to suppress elevated ACTH and antagonize masculinization. Endocr J. 1995 ; 42 (4). 505-508.
    • (1995) Endocr J , vol.42 , Issue.4 , pp. 505-508
    • Kageyama, Y.1    Kitahara, S.2    Tsukamoto, T.3    Tsujii, T.4    Goto, S.5    Oshima, H.6
  • 52
    • 0034874411 scopus 로고    scopus 로고
    • The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia
    • Murakoshi M., Ikeda R., Fukui N. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia. J Toxicol Sci. 2001 ; 26 (3). 119-127.
    • (2001) J Toxicol Sci , vol.26 , Issue.3 , pp. 119-127
    • Murakoshi, M.1    Ikeda, R.2    Fukui, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.